London, New York and Chicago-based Celoxica is planning to expand its sales and marketing presence in the US and Europe on the back of its latest funding round.
Having been spun out of Oxford University in 1996, Celoxica provides trading services to automated trading firms, banks and brokers which need to improve the performance of trading applications.
As well as expanding its sales and marketing efforts, the UK-headquartered business will also be injecting further capital into technology development.
Speaking to GrowthBusiness, Colin Watts, investment director at Oxford Capital Partners, says, ‘Institutions involved in high frequency trading need systems which enable them to interrogate data instantly and execute deals faster if they are to stay ahead of the competition.
‘We have led the latest funding round with our partners to give the business the resources it needs to gear up its global sales and marketing to capitalise on its strong market position.’
To coincide with the $3 million (£2 million) funding round, Celoxica has launched its Generic Book Accelerator product line for the US markets. The new product is aimed at providing ‘ultra low latency’ market data, order entry and pre-trade risk services.
More on Oxford Capital Partners:
- iJento receives backing from multiple VC sources
- Oxford Capital Partners amongst winners at 2012 awards
Jean Marc Bouhelier, chairman and CEO of Celoxica, adds, ‘In a market where margins are being continually squeezed and where performance remains of paramount importance, our goal is to deliver state-of-the-art technology solutions the help our clients address these challenges whilst reducing their total cost of ownership.
‘Our sales and marketing expansion will ensure that more trading firms, banks and brokers are aware of how Celoxica’s unique and cost-effective offering can help them surmount and thrive these industry trends.’
In an interview with GrowthBusiness back in April, Oxford Capital Partners co-founder David Mott said that the firm is still very interested in the mobile phenomenon that is going on and, combined with being active in big data and the cloud, is somewhere it expects to make returns.
Joining Oxford Capital Partners in the Celoxica funding round are all existing institutional investors.
